| Literature DB >> 30109223 |
Alexander Carreño1,2, Leonardo Rodríguez3, Dayán Páez-Hernández1, Rudy Martin-Trasanco1, César Zúñiga1, Diego P Oyarzún1, Manuel Gacitúa4, Eduardo Schott5, Ramiro Arratia-Pérez1, Juan A Fuentes3.
Abstract
It has been reported that the structure of the Schiff bases is fundamental for their function in biomedical applications. Pyridine Schiff bases are characterized by the presence of a pyridine and a phenolic ring, connected by an azomethine group. In this case, the nitrogen present in the pyridine is responsible for antifungal effects, where the phenolic ring may be also participating in this bioactivity. In this study, we synthesized two new pyridine Schiff Bases: (E)-2-[(3-Amino-pyridin-4-ylimino)-methyl]-4,6-difluoro-phenol (F1) and (E)- 2-[(3-Amino-pyridin-4-ylimino)-methyl]-6-fluoro-phenol (F2), which only differ in the fluorine substitutions in the phenolic ring. We fully characterized both F1 and F2 by FTIR, UV-vis, 1H; 13C; 19F-NMR, DEPT, HHCOSY, TOCSY, and cyclic voltammetry, as well as by computational studies (DFT), and NBO analysis. In addition, we assessed the antifungal activity of both F1 (two fluorine substitution at positions 4 and 6 in the phenolic ring) and F2 (one fluorine substitution at position 6 in the phenolic ring) against yeasts. We found that only F1 exerted a clear antifungal activity, showing that, for these kind of Schiff bases, the phenolic ring substitutions can modulate biological properties. In addition, we included F1 and F2 into in epichlorohydrin-β-cyclodextrin polymer (βCD), where the Schiff bases remained inside the βCD as determined by the ki , TGA, DSC, and SBET. We found that the inclusion in βCD improved the solubility in aqueous media and the antifungal activity of both F1 and F2, revealing antimicrobial effects normally hidden by the presence of common solvents (e.g., DMSO) with some cellular inhibitory activity. The study of structural prerequisites for antimicrobial activity, and the inclusion in polymers to improve solubility, is important for the design of new drugs.Entities:
Keywords: Cryptococcus; DFT calculations; antifungal agents; epichlorohydrin-β-cyclodextrin polymer; intramolecular hydrogen bonds; schiff base
Year: 2018 PMID: 30109223 PMCID: PMC6080543 DOI: 10.3389/fchem.2018.00312
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
Figure 1Molecular models of the (E)-2-[(3-Amino-pyridin-4-ylimino)-methyl]-4,6-difluoro-phenol (F1) and (E)- 2-[(3-Amino-pyridin-4-ylimino)-methyl]-6-fluoro-phenol (F2), the two pyridine Schiff bases analyzed in this study.
Figure 2Molecular models for F1 and F2 compounds. The energy of the frontier orbital HOMO-LUMO is presented in eV.
Figure 3CV profiles of F1, F2 (straight lines) and blank (dashed lines). Interphase: Pt| 0.01 mol L−1 of compound + 0.1 mol L−1 of TBAPF6 in anhydrous CH3CN under an argon atmosphere. Scan rate: 200 mV s−1.
Electrochemical signals description for F1 and F2.
| +1.07 (irr−d) | −0.89 (qrev−d) | |
| +0.92 (irr−nd) | −1.31 (irr−d) | |
Ox, oxidation; red, reduction; irr, irreversible; qrev, quasi-reversible; d, diffusional; nd, not diffusional.
Figure 4AL-Phase solubility diagram of βF1 (●) and βF2 (■) in presence of βCD. [D] corresponded to the total concentration of the guest (mol/L) (i.e., F1 or F2); [βCD] corresponded to the total concentration of cyclodextrin in the polymer (mol/L); S0 (mol/L) was the intrinsic solubility of the guest in water (see Equation 2).
k (inclusion constant) calculated from the AL-type phase-solubility diagram for βF1 and βF2 in βCD.
| Slope × 102 | 2.3 ± 0.8 | 7.6 ± 0.5 |
| S0·104 (mol L−1) | 5.1 ± 0.9 | 7.5 ± 0.9 |
| 45 ± 13 | 101 ± 10 |
Standard deviation.
Figure 5(A) Thermogravimetry analysis (TGA), and (B) DSC thermograms of F1, F2, βCD, βF1, and βF2.
Thermal decomposition temperature (TDT).
| 100:0 | 241.1 | – | – | 75.3 | 91.2 | |
| 100:0 | 238.4 | – | – | 77.6 | 93.4 | |
| 0:100 | 308.3 | 6.43 | 10.8 | 18.8 | 91.9 | |
| 50:50 | 345.6 | 7.87 | 9.12 | 13.1 | 88.6 | |
| 50:50 | 330.0 | 6.95 | 9.03 | 12.6 | 89.1 | |
SB, Schiff base (i.e., .
Parameters obtained from nitrogen adsorption–desorption analysis at 77 K.
| 1.87 | 4.37 | |
| 93.50 | 3.81 | |
| 89.56 | 3.90 |
S.
Figure 6Representation of the inclusion complex of (A) βF2 and (B) βF1 inside βCD cavity.
Minimal inhibition concentration (μg/mL) of tested compounds.
| 6.5 ± 1.2 | 7.8 ± 0.5 | 7.4 ± 0.5 | – | – | – | |
| – | – | – | – | – | – | |
| ND | 33.3 ± 14.4 | – | ND | – | – | |
| ND | – | – | ND | – | – | |
| Fluconazole | 5.8 ± 1.4 | 9.2 ± 2.3 | 10.2 ± 3.2 | – | – | – |
SE, Standard error; –, Undistinguishable from DMSO alone (i.e., no effect); ND, Not determined;
.
Minimal inhibition concentration (μg/mL) of tested compounds included in βCD.
| 100.0 ± 0.0 | 200.0 ± 0.0 | 200.0 ± 0.0 | 100.0 ± 0.0 | 122.2 ± 22.2 | 188.9 ± 11.1 | |
| 188.9 ± 11.1 | NE | NE | 200.0 ± 0.0 | NE | NE | |
| NE | NE | NE | NE | NE | NE | |
SE, Standard error; NE, No effect.